It was found that the top 1% of the top 1% of investment yields made large net purchases of bio companies’ stocks in the stock market on the morning of the 30th.
Instead, nuclear power
and the defense industry-related owners to take profit.
According to Mirae Asset M Club
The stock that the top 1% of investors who bought and sold stocks through the company net bought the most until 10 a.m. on the same day was Boxcell Bio.
The company’s stock price recently plunged as it announced that it would end clinical trials for multiple myeloma treatment candidates early and develop new treatments. In addition, suspicions have been raised that only data beneficial to the company were posted in the announcement that notified the early termination of the clinical trial.
However, the stock price is fluctuating as Bakcell Bio refutes these allegations and announces that it will present preliminary research results for liver cancer treatment candidates at an international conference to be held next month.
Eutilex’s stock price surged after KB Securities’ analysis that the clinical trials of three new drug candidates were cruising on the 25th, and has been undergoing correction for the third trading day.
other than
, , etc. were ranked in the top of the net buying by the experts.
On the other hand, Doosan Energy, Hanwha Aerospace, and Hanwha Aerospace were selected as the stocks with the most net sellers until 10 a.m. on the same day. It seems that they are offering take-profit offerings on stocks that have recently been on the uptrend.
By Han Kyung-woo, reporter at Hankyung.com [email protected]
※If you want to receive the news of Hankyung Market PRO as soon as possible telegramYou can subscribe to